EUVIMEDEUVIMED entdecken
Crossref

The Impact of Airway Obstruction on Feno Values in Asthma Patients

Alain Michils, Maud Akset, Amaryllis Haccuria, Silvia Perez-Bogerd, Andreï Malinovschi, Alain Van Muylem

The Journal of Allergy and Clinical Immunology: In Practice · 2024

DOI: 10.1016/j.jaip.2023.08.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024. Verfasst von Alain Michils und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chest Department, Erasme University Hospital, Université libre de Bruxelles, Brussels, Belgium. Hauptthemen laut MEDLINE: Asthma, Airway Obstruction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Exhaled nitric oxide (Feno) is used as a marker of type-2 airway inflammation in asthma management. Studies with airway challenges demonstrated that a reduction in airway caliber decreases Feno levels. OBJECTIVE: To evaluate the impact of airway caliber reduction occurring spontaneously in patients with asthma on Feno values in daily clinical practice. METHODS: In this post hoc analysis, Feno, FEV1, and asthma control questionnaire scores were recorded on each visit for 120 (1073 visits) adult patients with asthma. Blood eosinophils were measured intermittently. The intraindividual relationship between Feno and FEV1 was evaluated via a linear mixed model. The determinants of the individual mean Feno were measured by a stepwise multivariate linear model including individual mean FEV1, inhaled corticosteroid dose, asthma control questionnaire score, and blood eosinophils. RESULTS: Variations in the negative Feno-FEV1 relationship within individuals at different times were significantly determined by the individual's mean FEV1. This relationship did not hold for individuals above the 75th and below the 25th quartiles. The best explanatory variables for individual mean Feno were FEV1 (+4.3 parts per billion/10%pred) and blood eosinophil count (+1 part per billion per 100 cells/mm3). DISCUSSION: In the presence of variable degrees of heterogeneous patterns of airway inflammation, airway caliber is shown to be an independent and significant determinant of Feno when measured in patients with asthma. We would propose a +4-parts-per-billion correction factor to the measured Feno value for each 10% reduction below 100% predicted FEV1. Doing this should improve the rigor of interpretation of Feno as an indicator of type-2 inflammation in patients with low FEV1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaAirway ObstructionAdultHumansRespiratory SystemEosinophilsInflammationNitric OxideBreath Tests

Stichwörter der Autor:innen

AsthmaBlood eosinophilsFEV(1)Fractionated exhaled nitric oxide

Substanzen

Nitric Oxide

Autor:innen und Institutionen

  • Chest Department, Erasme University Hospital, Université libre de Bruxelles, Brussels, Belgium.
  • Department of Medical Sciences: Clinical Physiology, Uppsala University, Uppsala, Sweden.
  • Chest Department, Erasme University Hospital, Université libre de Bruxelles, Brussels, Belgium. Electronic address: Alain.Van.Muylem@hubruxelles.be.

Zitieren

APA

Michils, A., Akset, M., Haccuria, A., Perez-Bogerd, S., Malinovschi, A., & Van Muylem, A. (2024). The Impact of Airway Obstruction on Feno Values in Asthma Patients. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.08.027

Vancouver

Michils A, Akset M, Haccuria A, Perez-Bogerd S, Malinovschi A, Van Muylem A. The Impact of Airway Obstruction on Feno Values in Asthma Patients. The Journal of Allergy and Clinical Immunology: In Practice. 2024. doi:10.1016/j.jaip.2023.08.027

BibTeX
@article{Michils2024,
  author = {Michils, Alain and Akset, Maud and Haccuria, Amaryllis and Perez-Bogerd, Silvia and Malinovschi, Andreï and Van Muylem, Alain},
  title = {The Impact of Airway Obstruction on Feno Values in Asthma Patients},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  doi = {10.1016/j.jaip.2023.08.027}
}
Kostenlos starten →